Drug
Sphingomod
Sphingomod: highest development phase Phase 1, developed by Hikma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hikma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sphingomod NCT04657744 | Phase 1 | Healthy |
Latest
No recent events.
Follow Sphingomod on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.